Results
SD, pain
ADVERSE EVENTS
In this clinical trial, data of all 140 patients were evaluable (Fig. CONSORT flow of clinical procedures. S, normal saline; R, remimazolam.Demographic data of patients (n = 70 in each group).Notes: Data are displayed as means ± SD or number of cases. No statistically significant differences were noted between the two groups.S, Normal saline; R, remimazolam.The incidence and intensity of PIP during propofol injection and patient satisfaction of the gastroscopy in the two groups are shown in Table Incidence of propofol induced injection pain and patient satisfaction (n = 70 in each group).Notes: Data are displayed as the number of cases. Chi-square test were used to analyze the incidence of PIP. *S, Normal saline; R, remimazolam.The difference of sex on the severity of pain between the two groups. Notes: Data are displayed as the number of cases. Severity of pain: 0, no pain; 1, mild pain; 2, moderate pain; 3, severe pain. S, normal saline; R, remimazolam.The incidence of adverse events between the two groups is shown in Table Incidence of adverse events between two groups (n = 70 in each group).Notes: Data are displayed as the number of cases. Chi-square test were used to analyze the incidence of an adverse events.S, Normal saline; R, remimazolam.The characteristics of anesthesia, surgery, and recovery time are shown in Table Characteristics of anesthesia and surgery (n = 70 in each group).Notes: Data are all displayed as means ± SD. Independent sample S, Normal saline; R, remimazolam.There were no significant differences in systolic blood pressure (SBP), diastolic blood pressure (DBP), mean artery pressure (MAP), HR, and SpOChanges of vital signs (